Cadian Capital Management, LP Evolus, Inc. Transaction History

Cadian Capital Management, LP

  • $1.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020
SELL
$3.53 - $12.21 $1.8 Million - $6.22 Million
-509,396 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$11.58 - $17.37 $2.03 Million - $3.04 Million
175,000 Added 52.33%
509,396 $6.2 Million
Q3 2019

Nov 13, 2019
BUY
$13.91 - $19.87 $4.65 Million - $6.64 Million
334,396 New
334,396 $5.22 Million

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Cadian Capital Management, LP Portfolio

Follow Cadian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cadian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email